Dyadic international to present at upcoming scientific medical meetings

Jupiter, fla., april 04, 2022 (globe newswire) -- dyadic international, inc. (“dyadic”, or the “company”) (nasdaq: dyai) a global biotechnology company focused on further improving, applying and deploying its proprietary c1-cell protein production platform to accelerate development, lower production costs and improve the performance of biologic vaccines and drugs at flexible commercial scales, today announced that its management and representatives will be presenting at the following scientific medical meetings:
DYAI Ratings Summary
DYAI Quant Ranking